Answers are grounded in this paper and cite their sources.
Real-world cohort study evaluates survival outcomes of trastuzumab deruxtecan in patients with brain metastases, indicating implications for treatment strategy.
This study evaluated the real-world effectiveness of trastuzumab deruxtecan (T-DXd) in patients with breast cancer brain metastases (BCBM), generating data from populations underrepresented in clinical trials. Patients with BCBM treated with T-DXd across seven U.S. health systems from 2019 to 2023 were retrospectively identified. HER2 status was classified as HER2-positive (IHC 3 + or IHC 2+/FISH+) or HER2-low (IHC 1 + or IHC 2+/FISH-). Overall survival (OS) was the primary outcome and was evaluated using Kaplan-Meier and log-rank methods for unadjusted comparisons followed by multivariable Cox regression. A total of 111 patients were included (HER2-positive, n = 77; HER2-low, n = 34). HER2-low tumors were more often ER-positive than HER2-positive tumors (79.4% vs. 56.6%, respectively). Overall, 46.8% of patients had received ≥ 6 prior systemic therapy lines. In unadjusted analyses, greater prior chemotherapy exposure was associated with shorter OS (median OS not reached for 0 lines, 35.2 months for 1-2 lines, and 22.1 months for ≥ 3 lines). Median OS was longer in HER2-positive than HER2-low disease (35.2 vs. 12.8 months, respectively). In multivariable analysis, receipt of ≥ 3 prior chemotherapy lines was associated with shorter OS (aHR 9.95, 95% CI 1.20-82.53; p = 0.033), although this finding should be interpreted cautiously given the small sample size, wide confidence interval, and pooled analysis across HER2 subgroups. In this real-world cohort of patients with BCBM treated with T-DXd, HER2-positive disease was associated with longer unadjusted survival than HER2-low disease. Greater prior chemotherapy exposure may reflect poorer underlying prognosis and more heavily pretreated disease.
No takes yet. Share an insight, caveat, or question.
Podder et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: